25 related articles for article (PubMed ID: 24835925)
1. Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells.
Sobot D; Mura S; Rouquette M; Vukosavljevic B; Cayre F; Buchy E; Pieters G; Garcia-Argote S; Windbergs M; Desmaële D; Couvreur P
Mol Ther; 2017 Jul; 25(7):1596-1605. PubMed ID: 28606375
[TBL] [Abstract][Full Text] [Related]
2. Thiophene-expanded guanosine analogues of Gemcitabine.
Chen Z; Ku TC; Seley-Radtke KL
Bioorg Med Chem Lett; 2015 Oct; 25(19):4274-6. PubMed ID: 26316465
[TBL] [Abstract][Full Text] [Related]
3. Cyanine-Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells.
Jiang Z; Pflug K; Usama SM; Kuai D; Yan X; Sitcheran R; Burgess K
J Med Chem; 2019 Oct; 62(20):9236-9245. PubMed ID: 31469566
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine lipid prodrug nanoparticles: Switching the lipid moiety and changing the fate in the bloodstream.
Coppens E; Desmaële D; Naret T; Garcia-Argote S; Feuillastre S; Pieters G; Cailleau C; Paul JL; Prost B; Solgadi A; Michel JP; Noiray M; Couvreur P; Mura S
Int J Pharm; 2021 Nov; 609():121076. PubMed ID: 34481886
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a deuterated probe for the confocal Raman microscopy imaging of squalenoyl nanomedicines.
Buchy E; Vukosavljevic B; Windbergs M; Sobot D; Dejean C; Mura S; Couvreur P; Desmaële D
Beilstein J Org Chem; 2016; 12():1127-35. PubMed ID: 27559365
[TBL] [Abstract][Full Text] [Related]
6. Vesicular self-assembly of a natural ursane-type dihydroxy-triterpenoid corosolic acid.
Bag BG; Garai C; Ghorai S
RSC Adv; 2019 May; 9(27):15190-15195. PubMed ID: 35514858
[TBL] [Abstract][Full Text] [Related]
7. Azacitidine Omega-3 Self-Assemblies: Synthesis, Characterization, and Potent Applications for Myelodysplastic Syndromes.
Baroud M; Lepeltier E; El-Makhour Y; Lautram N; Bejaud J; Thepot S; Duval O
Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959720
[TBL] [Abstract][Full Text] [Related]
8. Squalenoylation: a generic platform for nanoparticular drug delivery.
Desmaële D; Gref R; Couvreur P
J Control Release; 2012 Jul; 161(2):609-18. PubMed ID: 21840355
[TBL] [Abstract][Full Text] [Related]
9. Two Possible Strategies for Drug Modification of Gemcitabine and Future Contributions to Personalized Medicine.
Pereira M; Vale N
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011522
[TBL] [Abstract][Full Text] [Related]
10. Self-assembly of polyisoprenoyl gemcitabine conjugates: influence of supramolecular organization on their biological activity.
Lepeltier E; Bourgaux C; Maksimenko A; Meneau F; Rosilio V; Sliwinski E; Zouhiri F; Desmaële D; Couvreur P
Langmuir; 2014 Jun; 30(22):6348-57. PubMed ID: 24835925
[TBL] [Abstract][Full Text] [Related]
11. Polymer prodrug nanoparticles based on naturally occurring isoprenoid for anticancer therapy.
Trung Bui D; Maksimenko A; Desmaële D; Harrisson S; Vauthier C; Couvreur P; Nicolas J
Biomacromolecules; 2013 Aug; 14(8):2837-47. PubMed ID: 23829862
[TBL] [Abstract][Full Text] [Related]
12. Polyisoprenoyl gemcitabine conjugates self assemble as nanoparticles, useful for cancer therapy.
Maksimenko A; Mougin J; Mura S; Sliwinski E; Lepeltier E; Bourgaux C; Lepêtre S; Zouhiri F; Desmaële D; Couvreur P
Cancer Lett; 2013 Jul; 334(2):346-53. PubMed ID: 22935679
[TBL] [Abstract][Full Text] [Related]
13. Decoration of Squalenoyl-Gemcitabine Nanoparticles with Squalenyl-Hydroxybisphosphonate for the Treatment of Bone Tumors.
Rodríguez-Nogales C; Desmaële D; Sebastián V; Couvreur P; Blanco-Prieto MJ
ChemMedChem; 2021 Dec; 16(24):3730-3738. PubMed ID: 34581019
[TBL] [Abstract][Full Text] [Related]
14. Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes.
Bildstein L; Pili B; Marsaud V; Wack S; Meneau F; Lepêtre-Mouelhi S; Desmaële D; Bourgaux C; Couvreur P; Dubernet C
Eur J Pharm Biopharm; 2011 Nov; 79(3):612-20. PubMed ID: 21784150
[TBL] [Abstract][Full Text] [Related]
15. Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.
Reddy LH; Renoir JM; Marsaud V; Lepetre-Mouelhi S; Desmaële D; Couvreur P
Mol Pharm; 2009; 6(5):1526-35. PubMed ID: 19634915
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
